Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
CDT Equity Inc. amended Amendment to Agreement and Plan of Merger with Conduit Merger Sub, Inc. and Conduit Pharmaceuticals Limited valued at Amended the original merger agreement to provide for only one class of common stock and to grant reg (effective 2023-01-27).
- Action
- amendment
- Agreement
- merger
- Counterparty
- Conduit Merger Sub, Inc. and Conduit Pharmaceuticals Limited
- Value
- Amended the original merger agreement to provide for only one class of common stock and to grant reg
- Effective
- 2023-01-27
Exact text from the filing
On January 27, 2023, the Company entered into an Amendment to Agreement and Plan of Merger (the “Merger Amendment” and, together with the Original Merger Agreement, the “Merger Agreement”) with Merger Sub and Conduit.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
CDT Equity Inc. amended Amendment to Subscription Agreement with Private Placement Investor valued at Clarified that the Company will have only one class of common stock and amended the warrants to be i (effective 2023-01-27).
- Action
- amendment
- Agreement
- equity purchase
- Counterparty
- Private Placement Investor
- Value
- Clarified that the Company will have only one class of common stock and amended the warrants to be i
- Effective
- 2023-01-27
Exact text from the filing
Also on January 27, 2023, the Company entered into an amendment to subscription agreement (the “Subscription Amendment”) with the Private Placement Investor to clarify that the Company will only have one class of authorized common stock following the Conduit Business Combination and to amend and restate the warrants to be issued to the Private Placement Investor accordingly (the “Amended and Restated Warrants”).
View on SEC.gov